As of 2026-05-25, the EV/EBITDA ratio of Thyrocare Technologies Ltd (THYROCARE.NS) is 28.76. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. THYROCARE.NS's latest enterprise value is 73,688.14 mil INR. THYROCARE.NS's TTM EBITDA according to its financial statements is 2,562.50 mil INR. Dividing these 2 quantities gives us the above THYROCARE.NS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 14.5x - 23.0x | 17.2x |
| Forward P/E multiples | 6.8x - 18.1x | 10.9x |
| Fair Price | 102.31 - 373.82 | 221.20 |
| Upside | -78.0% - -19.8% | -52.5% |
| Date | EV/EBITDA |
| 2026-05-22 | 28.76 |
| 2026-05-21 | 28.89 |
| 2026-05-20 | 29.32 |
| 2026-05-19 | 28.97 |
| 2026-05-18 | 27.98 |
| 2026-05-15 | 28.46 |
| 2026-05-14 | 29.02 |
| 2026-05-13 | 29.51 |
| 2026-05-12 | 29.14 |
| 2026-05-11 | 29.54 |
| 2026-05-08 | 30.01 |
| 2026-05-07 | 29.17 |
| 2026-05-06 | 28.57 |
| 2026-05-05 | 26.71 |
| 2026-05-04 | 25.96 |
| 2026-04-30 | 24.67 |
| 2026-04-29 | 25.19 |
| 2026-04-28 | 25.08 |
| 2026-04-27 | 25.60 |
| 2026-04-24 | 24.30 |
| 2026-04-23 | 24.36 |
| 2026-04-22 | 24.48 |
| 2026-04-21 | 23.86 |
| 2026-04-20 | 23.99 |
| 2026-04-17 | 24.17 |
| 2026-04-16 | 24.36 |
| 2026-04-15 | 24.60 |
| 2026-04-13 | 24.57 |
| 2026-04-10 | 24.54 |
| 2026-04-09 | 24.17 |
| 2026-04-08 | 24.13 |
| 2026-04-07 | 23.24 |
| 2026-04-06 | 23.25 |
| 2026-04-02 | 22.49 |
| 2026-04-01 | 22.31 |
| 2026-03-30 | 21.65 |
| 2026-03-27 | 22.27 |
| 2026-03-25 | 22.92 |
| 2026-03-24 | 22.51 |
| 2026-03-23 | 22.42 |
| 2026-03-20 | 21.83 |
| 2026-03-19 | 22.38 |
| 2026-03-18 | 22.98 |
| 2026-03-17 | 22.36 |
| 2026-03-16 | 22.18 |
| 2026-03-13 | 21.87 |
| 2026-03-12 | 22.34 |
| 2026-03-11 | 22.62 |
| 2026-03-10 | 23.06 |
| 2026-03-09 | 23.36 |